HB 1323: Pharmaceutical Products Containing Cannabis

Summary

Excludes cannabis from Schedule I listing if it is contained within FDA-approved pharmaceutical product.

Bill details

Sponsor

Kaylee Tuck

Current status

Died in Committee

Introduced

January 11, 2022

Status history

1. Died in Committee — January 11, 2022
   Migrated from existing bill record
   Source